Trademark applications and grants for Biothera Inc. Biothera Inc has 8 trademark applications. The latest application filed is for "IMPRIME PGG"
Patent Application | Date |
---|---|
BETA-GLUCAN ASSAY METHODS 20190064179 - 16/171777 Bose; Nandita ;   et al. | 2019-02-28 |
BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT 20190060351 - 16/174177 BOSE; Nandita ;   et al. | 2019-02-28 |
BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT 20190060350 - 16/174157 BOSE; Nandita ;   et al. | 2019-02-28 |
BETA-GLUCAN IMMUNOTHERAPIES AFFECTING THE IMMUNE MICROENVIRONMENT 20190022129 - 16/068868 BOSE; Nandita ;   et al. | 2019-01-24 |
COMPOSITIONS AND METHODS FOR BETA-GLUCAN IMMUNOTHERAPY 20180369376 - 16/118909 Grossman; William J. ;   et al. | 2018-12-27 |
NCAGE Code | 46VW0 | BIOTHERA, INC.!DBA BIOTHERA |
CAGE Code | 46VW0 | BIOTHERA, INC. BIOTHERA |
S.A.M. Registration | 46VW0 [177980927] | BIOTHERA, INC. BIOTHERA |
SEC | 0001303653 | Biothera, Inc. of MINNESOTA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.